Keri Medical and Medartis Holding enter into a strategic partnership. The advisors

Keri Medical, a Geneva-based company specialized in implants for hand and wrist surgery, and Medartis Holding have entered into a strategic equity and commercial partnership. In this transaction, Medartis Holding invested CHF 10 million in Keri Medical, acquiring a 25% strategic minority stake. A significant portion of the investment’s proceeds will be used for access and development of the US market for Keri Medical’s portfolio. The transaction also includes a partnership in distribution to drive the international expansion of Keri Medical’s portfolio, as well as in product development in the area of arthroplasty in small joints and soft tissue fixation in upper extremities.

The team

Lenz & Staehelin advised Keri Medical in this transaction. The team comprised Jacques Iffland (Corporate – pictured), Daniel Schafer (Tax), Federico Trabaldo Togna (Corporate and M&A), Sevan Antreasyan and Nadja Flühler (both IP, Commercial and Contracts), and Yannick Bucher (Corporate).